<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND OBJECTIVE: Registrolesaf (Spanish Registry of <z:hpo ids='HP_0002725'>Systemic Lupus Erythematosus</z:hpo> and <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">Primary Antiphospholipid Syndrome</z:e> through Internet) enables little known aspects of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> to be studied simply </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to analyze the features of patients included in Registrolesaf by rheumatologists and internists </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHOD: Among other data, Registrolesaf collects data on the specialty of physicians using the registry and patients' initials, date of birth, diagnosis, sex, vital status and, optionally, the ACR criteria on <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> and consensus statement criteria on <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: From May 2003 to November 2004, 1421 patients were included in the registry (1269 with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> and 152 with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>Rheumatologists included 462 (47.8%) <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> patients and 24 (16.7%) with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, while internists included 490 patients (50.7%) with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> and 119 (82.6%) with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Logistic regression analysis, controlled for age at diagnosis, disease duration and sex, showed that <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> patients included by internists had a higher frequency of malar <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> (OR 1.6; 95% CI 1.2-2.2), <z:hpo ids='HP_0000155'>oral ulcers</z:hpo> (OR 1.2; 95% CI 1.4-2.7), neuro-psychiatric manifestations (OR 2.2; 95% CI 1.3- 3.8), <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> (OR 1.5; 95% CI 1-2) andantinuclear antibodies (OR 2.1; 95% CI 0.97-4.7), while the frequency of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (OR 0.6; 95% CI 0.4-0.9) and the number of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> criteria (P=.002) were lower </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Rheumatologists and internists have a similar approach to patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, although internists could include more seriously ill patients </plain></SENT>
</text></document>